Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pericentrin (PCNT) is a large, conserved scaffold protein of the pericentriolar material (PCM) at the centrosome, essential for organizing centrosomal matrix components during mitosis[1][3][4][5][6]. It serves as an anchor for a wide number of regulatory and structural proteins, including the γ-tubulin ring complex, facilitating microtubule nucleation and proper mitotic spindle formation for cell division[1][3][4][5][6]. PCNT is also implicated in DNA damage response via its interactions at the centrosome. Mutations in the PCNT gene are responsible for several congenital disorders featuring growth defects, such as microcephalic osteodysplastic primordial dwarfism type II and Seckel syndrome 4[2][3][4][6]. Increased PCNT expression has been observed in certain cancers, where it is associated with centrosomal abnormalities and chromosomal instability[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pericentrin (PCNT).